Pharmacokinetics of the H2‐ receptor antagonist ranitidine in man.

British Journal of Clinical Pharmacology

Volumn 12, Issue 3, 1981, Pages 411-415

  McNeil, JJ ^a   Mihaly, GW ^a   Anderson, A ^a   Marshall, AW ^a   Smallwood, RA ^a   Louis, WJ ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FURAN DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE; HISTAMINE H2 RECEPTOR;

ADULT; ARTICLE; BIOAVAILABILITY; HUMAN; KIDNEY; KINETICS; MALE; METABOLIC CLEARANCE RATE; METABOLISM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG RESPONSE; DRUG URINE LEVEL; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS;

ADULT; BIOLOGICAL AVAILABILITY; FURANS; HISTAMINE H2 ANTAGONISTS; HUMAN; KIDNEY; KINETICS; MALE; METABOLIC CLEARANCE RATE; RANITIDINE; SUPPORT, NON-U.S. GOV'T;

EID: 0019393543     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1981.tb01236.x     Document Type: Article

References (14)

1. 2‐receptor antagonist
2. The relevance to man of preclinical data for cimetidine
3. 2‐receptor antagonist, in healthy man
4. 2‐antagonists ranitidine and cimetidine
5. Pharmacokinetics, Vol. 1, In
6. Kinetics of cimetidine in man and experimental animals
7. Cimetidine and arrhvthmia suppression
8. Assessment of pharmacokinetic constants from post‐infusion blood curves after intravenous infusion
9. High pressure liquid chromatographic determination of Tanitidine
10. Inhibition of pentagastrin—stimulated and nocturnal gastric secretion by ranitidine
11. Pharmacologically effective plasma concentrations of ranitidine
12. Bradycardia after cimetidine
13. Bioavailability of cimetidine in man
14. 2‐receptor antagonist